Vericel Corporation (VCEL) Revenue History
Vericel Corporation (VCEL) annual and quarterly revenue history with charts. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $54.38M |
| 2017-12-31 | $63.92M |
| 2018-12-31 | $90.86M |
| 2019-12-31 | $117.85M |
| 2020-12-31 | $121.97M |
| 2021-12-31 | $153.07M |
| 2022-12-31 | $163.70M |
| 2023-12-31 | $197.52M |
| 2024-12-31 | $237.22M |
| 2025-12-31 | $276.26M |
How VCEL compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| EOLS | Evolus Inc. | $297.18M |
| RIGL | Rigel Pharmaceuticals Inc. | $294.28M |
| HROW | Harrow Inc Com | $272.30M |
| IOVA | Iovance Biotherapeutics Inc. | $263.50M |
| AKBA | Akebia Therapeutics Inc. | $236.20M |
These are five companies in the same sector as VCEL with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Vericel Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("VCEL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | VCEL | $44.35 | +0.91% | 0.42M |
| 3 | ||||
| 4 | ||||
| 5 |